Sophie Derniame

Director, CMC Program Management at Cellectis

Sophie Derniame is an experienced professional in cell manufacturing and technology transfer, currently serving as the Director of CMC Program Management and Director of Technology Transfers at Cellectis since January 2013. Previously, Sophie held various roles including Manufacturing Project Manager and Scientist - Project Leader, focusing on process and assay development for UCART cell manufacturing. Prior experiences include research associate positions at Anthony Nolan, University College London, and Imperial College London, contributing to projects related to stem cell transplantation, gene therapy, and molecular immunology. Sophie holds a PhD in Lung cancer/local immune response from Université Henri Poincaré, Nancy 1, and a Master's degree in Microbiology, Enzymology, and Nutrition from the same institution.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Cellectis

1 followers

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy.


Industries

Headquarters

Paris, France

Employees

51-200

Links